[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100489557":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":31,"responsibleParty":48,"collaborators":10,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Academisch Ziekenhuis Maastricht","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Oncologic patients",null,"Lymphoma and lung cancer patients will undergo an additional dynamic FDG PET\u002FCT examination on top of their standard care PET\u002FCT examination.\n\nIn addition, blood samples will be drawn at three time points",[13],"Diagnostic Test: FDG PET\u002FCT",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","FDG PET\u002FCT","Besides the standard care FDG PET\u002FCT examination, subjects receive a dynamic whole body PET\u002FCT examination.",[9],[21],{"name":22,"affiliation":23,"role":24},"Roel Wierts, PhD","Medical physicist","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Sam Springer, MSc","CONTACT","+31433874907","sam.springer@mumc.nl",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Academisch ziekenhuis Maastricht","RECRUITING","Maastricht","Limburg","6229 HX","Netherlands","NL",{"type":41,"coordinates":42},"Point",[43,44],5.68889,50.84833,{"lat":44,"lon":43},[47],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},{"type":24,"investigatorFullName":49,"investigatorTitle":23,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Roel Wierts","100489557","evaluation-of-the-use-of-the-fur-to-quantify-tumor-glucose-consumption-in-oncologic-pet-100489557",false,"NCT05654675","Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET","Evaluation of the Fractional Uptake Rate (FUR) in 18F-FDG PET\u002FCT to Assess Tumour Metabolic Activity","Inclusion Criteria:\n\n* Patients who receive an 18F FDG PET\u002FCT scan as part of standard care\n* Be competent and be 18 years of age or older\n\nExclusion Criteria:\n\n* Diabetes (fasted blood glucose \\> 7 mmol\u002FL)\n* Not fasted \\> 4 hours\n* Physical exercise within 24 hours\n* Earlier treatment for carcinoma with radio\u002Fchemo-therapy\n* Active inflammation (fever \\> 38 degrees, CRP \\> 5)\n* Any condition or medical indication (such as claustrophobia) that indicates that the patient will not be able to lie still for the duration of the dynamic PET\u002FCT examination\n* Pregnant or breast feeding","ALL","18 Years",{"count":60,"type":61},30,"ESTIMATED","OBSERVATIONAL","The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET\u002FCT. The main questions it aims to answer are:\n\n* Is the new quantification method superior with respect to the method currently used in the clinic?\n* Does the new quantification method provide accurate assessment of the sugar consumption of tumours?\n\nParticipants who will undergo a standard care FDG PET\u002FCT scan will in additional receive a dynamic PET\u002FCT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.",[65,66],"Lung Cancer","Lymphoma",[68,69,70,71],"PET\u002FCT","FDG","SUV","FUR","2025-01-28",{"date":74,"type":75},"2025-01-29","ACTUAL",{"date":77,"type":75},"2024-01-15",{"date":79,"type":61},"2025-06-01",{"name":5,"class":6},1]